Israeli Medical Device Company IceCure Receives China Approval for Cancer Treatment System
Israeli firm IceCure Medical has gained China's National Medical Products Administration approval for its ProSense cryoablation system, expanding cancer.
ProSense
Israeli IceCure Expands Cancer Treatment Technology in Netherlands
Israeli firm IceCure Medical partners with Scovas Medical for exclusive distribution of its ProSense cryoablation cancer treatment in the Netherlands.
Israeli Tumor-Freezing Technology Gains Ground in Brazil
IceCure Medical's tumor-freezing ProSense technology is gaining commercial traction in Brazil for breast, lung, kidney, and musculoskeletal tumors.
Israeli Medtech Firm IceCure Gains FDA Approval for Post-Market Breast Cancer Study
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".